Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty

被引:131
|
作者
Robert, Philippe H. [1 ,2 ]
Koenig, Alexandra [1 ,3 ]
Amieva, Helene [4 ]
Andrieu, Sandrine [5 ,6 ,7 ]
Bremond, Francois [1 ,8 ]
Bullock, Roger [9 ]
Ceccaldi, Mathieu [10 ]
Dubois, Bruno [11 ,12 ]
Gauthier, Serge [13 ]
Kenigsberg, Paul-Ariel [14 ]
Nave, Stephane [15 ]
Orgogozo, Jean M. [16 ]
Piano, Julie [2 ]
Benoit, Michel [1 ]
Touchon, Jacques [17 ]
Vellas, Bruno [18 ,19 ]
Yesavage, Jerome [20 ,21 ]
Manera, Valeria [1 ]
机构
[1] Univ Nice Sophia Antijpolis, EA CoBTeK IA, Nice, France
[2] CHU Nice, Ctr Memoire Ressources & Rech, F-06202 Nice, France
[3] Maastricht Univ, Sch Mental Hlth & Neurosci, Alzheimer Ctr Limburg, Maastricht, Netherlands
[4] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France
[5] Fac Med Toulouse, INSERM, UMR1027, F-31073 Toulouse, France
[6] Univ Toulouse 3, UMR1027, F-31062 Toulouse, France
[7] CHU Toulouse, Serv Epidemiol & Sante Publ, Toulouse, France
[8] INRIA STARS Sophia Antijpolis, Sophia Antijpolis, France
[9] Kingshill Res Ctr, Swindon, Wilts, England
[10] CHU Marseille, Ctr Memoire Ressources & Rech, Marseille, France
[11] CMRR CHU Paris, IM2A, INSERM, UMR S 975,ICM, Paris, France
[12] Univ Paris 06, Hop La Pitie Salpetriere, Paris, France
[13] McGill Ctr Studies Aging, Verdun, PQ, Canada
[14] Fdn Meder Alzheimer, Paris, France
[15] Roche, Ctr Memoire, pRED, Neurosci, Basel, Switzerland
[16] CHU Bordeaux, Ctr Memoire Ressources & Rech, Bordeaux, France
[17] CHU Montpellier, Ctr Memoire Ressources & Rech, Montpellier, France
[18] CHU Toulouse, INSERM, UMR 1027, Toulouse, France
[19] Univ Toulouse 3, INSERM, UMR1027, F-31062 Toulouse, France
[20] Palo Alto Vet Affairs Hlth Care Syst, Palo Alto, CA USA
[21] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA
来源
FRONTIERS IN AGING NEUROSCIENCE | 2014年 / 6卷
关键词
Alzheimer's disease; mild cognitive impairment; frailty; serious games; recommendations; rehabilitation; SWOT analysis; non pharmacological treatment; MILD COGNITIVE IMPAIRMENT; NURSING-HOME RESIDENTS; PREDICT INSTRUMENTAL ACTIVITIES; OF-THE-LITERATURE; APATHY; DEMENTIA; REHABILITATION; AGITATION; TECHNOLOGIES; PERFORMANCE;
D O I
10.3389/fnagi.2014.00054
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease and other related disorders (ADRD) represent a major challenge for health care systems within the aging population. It is therefore important to develop better instruments to assess the disease severity and progression, as well as to improve its treatment, stimulation, and rehabilitation. This is the underlying idea for the development of Serious Games (SG). These are digital applications specially adapted for purposes other than entertaining; such as rehabilitation, training and education. Recently, there has been an increase of interest in the use of SG targeting patients with ADRD. However, this field is completely uncharted, and the clinical, ethical, economic and research impact of the employment of SG in these target populations has never been systematically addressed. The aim of this paper is to systematically analyze the Strengths, Weaknesses, Opportunities, and Threats (SWOT) of employing SG with patients with ADRD in order to provide practical recommendations for the development and use of SG in these populations. These analyses and recommendations were gathered, commented on and validated during a 2-round workshop in the context of the 2013 Clinical Trial of Alzheimer's Disease (CTAD) conference, and endorsed by stakeholders in the field. The results revealed that SG may offer very useful tools for professionals involved in the care of patients suffering from ADRD. However, more interdisciplinary work should be done in order to create SG specifically targeting these populations. Furthermore, in order to acquire more academic and professional credibility and acceptance, it will be necessary to invest more in research targeting efficacy and feasibility. Finally, the emerging ethical challenges should be considered a priority.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders
    Wang, Zheng-Yu
    Han, Zhen-Min
    Liu, Qi-Fei
    Tang, Wei
    Ye, Kui
    Yao, Yu-You
    INTERNATIONAL PSYCHOGERIATRICS, 2015, 27 (09) : 1429 - 1438
  • [42] Comparison of olfactory and gustatory disorders in Alzheimer's disease
    Kouzuki, Minoru
    Suzuki, Tetsuya
    Nagano, Masaya
    Nakamura, Syouta
    Katsumata, Yuto
    Takamura, Ayumi
    Urakami, Katsuya
    NEUROLOGICAL SCIENCES, 2018, 39 (02) : 321 - 328
  • [43] Cardiac Disorders as Risk Factors for Alzheimer's Disease
    de Toledo Ferraz Alves, Tania Correa
    Ferreira, Luiz Kobuti
    Wajngarten, Mauricio
    Busatto, Geraldo F.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (03) : 749 - 763
  • [44] Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders
    Robert, P.
    Onyike, C. U.
    Leentjens, A. F. G.
    Dujardin, K.
    Aalten, P.
    Starkstein, S.
    Verhey, F. R. J.
    Yessavage, J.
    Clement, J. P.
    Drapier, D.
    Bayle, F.
    Benoit, M.
    Boyer, P.
    Lorca, P. M.
    Thibaut, F.
    Gauthier, S.
    Grossberg, G.
    Vellas, B.
    Byrne, J.
    EUROPEAN PSYCHIATRY, 2009, 24 (02) : 98 - 104
  • [45] Nutraceuticals: A Novel Concept in Prevention and Treatment of Alzheimer's Disease and Related Disorders
    Farias, Gonzalo A.
    Guzman-Martinez, Leonardo
    Delgado, Carolina
    Maccioni, Ricardo B.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (02) : 357 - 367
  • [46] Oxidative stress and inflammation are associated with physical frailty in patients with Alzheimer's disease
    Namioka, Nayuta
    Hanyu, Haruo
    Hirose, Daisuke
    Hatanaka, Hirokuni
    Sato, Tomohiko
    Shimizu, Soichiro
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2017, 17 (06) : 913 - 918
  • [47] The impact of Frailty on the risk of conversion from Mild cognitive impairment to alzheimer's Disease: evidences from a 5-Year Observational study
    Trebbastoni, Alessandro
    Canevelli, Marco
    D'Antonio, Fabrizia
    Imbriano, Letizia
    Podda, Livia
    Rendace, Lidia
    Campanelli, Alessandra
    Celano, Valentina
    Bruno, Giuseppe
    de Lena, Carlo
    FRONTIERS IN MEDICINE, 2017, 4
  • [48] Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
    Herukka, Sanna-Kaisa
    Simonsen, Anja Hviid
    Andreasen, Niels
    Baldeiras, Ines
    Bjerke, Maria
    Blennow, Kaj
    Engelborghs, Sebastiaan
    Frisoni, Giovanni B.
    Gabryelewicz, Tomasz
    Galluzzi, Samantha
    Handels, Ron
    Kramberger, Milica G.
    Kulczynska, Agnieszka
    Luis Molinuevo, Jose
    Mroczko, Barbara
    Nordberg, Agneta
    Oliveira, Catarina Resende
    Otto, Markus
    Rinne, Juha O.
    Rot, Uros
    Saka, Esen
    Soininen, Hilkka
    Struyfs, Hanne
    Suardi, Silvia
    Visser, Pieter Jelle
    Winblad, Bengt
    Zetterberg, Henrik
    Waldemar, Gunhild
    ALZHEIMERS & DEMENTIA, 2017, 13 (03) : 285 - 295
  • [49] Alzheimer's disease CSF biomarkers: clinical indications and rational use
    Niemantsverdriet, Ellis
    Valckx, Sara
    Bjerke, Maria
    Engelborghs, Sebastiaan
    ACTA NEUROLOGICA BELGICA, 2017, 117 (03) : 591 - 602
  • [50] Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD expert meeting
    Robert, P. H.
    Konig, A.
    Andrieu, S.
    Bremond, F.
    Chemin, I.
    Chung, P. C.
    Dartigues, J. F.
    Dubois, B.
    Feutren, G.
    Guillemaud, R.
    Kenisberg, P. A.
    Nave, S.
    Vellas, B.
    Verhey, F.
    Yesavage, J.
    Mallea, P.
    JOURNAL OF NUTRITION HEALTH & AGING, 2013, 17 (08) : 653 - 660